Apadenoson
Alternative Names: ATL 146e; BMS 068645; StedivazeLatest Information Update: 24 Oct 2021
At a glance
- Originator University of Virginia
- Developer Adenosine Therapeutics; Forest Laboratories
- Class Alkynes; Contrast media; Purine nucleosides; Small molecules
- Mechanism of Action Adenosine A2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Suspended Coronary disorders
- Discontinued Coronary artery restenosis; Inflammation; Inflammatory bowel diseases; Reperfusion injury; Septic shock; Spinal cord injuries